Search

everythinglearnresearchcommunity

for

Search:↓

Topical rapamycin may effectively treat fibrous papules on the face.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Isotretinoin treatment in Palestine shows poor adherence to guidelines, with common side effects and a need for better prescribing practices and patient education.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Baricitinib successfully treated severe hair loss.

Balancing lipophilicity and solubility is key for effective and safe ketorolac prodrugs.

Patients with alopecia areata should be checked for muscle spasms, diarrhea, and ANA to avoid missing Satoyoshi syndrome.

The inhibitor affects androgen metabolism but not ovarian function.

TS-13 speeds up hair regrowth after chemotherapy without affecting treatment effectiveness.

Serenoa repens extract, alone or with other supplements, improves urinary symptoms and lowers PSA levels.

Sox13 is a marker for early hair follicle development but not essential for skin and hair growth.

Sper-12 nanoparticles may help treat hair loss by delivering siRNA to target androgen receptors.

Setipiprant did not significantly improve hair growth in men with hair loss.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Keeping human skin stem cells is easier with low temperatures and mTOR inhibition.

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

The new drug delivery system effectively targets lung cancer cells.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Oral cyclosporin doesn't stop hair loss.